Sara Vandenwijngaert
Directeur/Bestuurslid bij THERAtRAME SA
Actieve functies van Sara Vandenwijngaert
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
QBIC Venture Partners BV
QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Private Equity Investor | 01-01-2021 | - |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Directeur/Bestuurslid | - | - |
Loopbaan van Sara Vandenwijngaert
Statistieken
Internationaal
België | 3 |
Operationeel
Private Equity Investor | 1 |
Director/Board Member | 1 |
Sectoraal
Finance | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
QBIC Venture Partners BV
QBIC Venture Partners BV Investment ManagersFinance QBIC Venture Partners BVBA (QBIC Venture Partners) is a venture capital firm founded in 2012 by Marc Zabeau. The firm is headquartered in Belgium. | Finance |
THERAtRAME SA
THERAtRAME SA BiotechnologyHealth Technology THERAtRAME SA is a drug discovery start-up company based in Liege, Belgium. The Belgian company aims to become a leader in the development and positioning of novel cancer therapies by exploring new target areas to develop innovative cancer therapies. THERAtRAME's discovery platform integrates unique sets of technologies to discover, develop, and position new drugs to beat reluctant cancers. The company exploits the latest scientific discoveries highlighting the unexpected importance of trna epitranscriptomics dynamics in cancer. THERAtRAME is looking for a drug discovery assay developer leader to join their team. The company was founded by Francesca Rapino, Pierre Close, and has a team of experienced professionals with backgrounds in life sciences, medico-marketing, and biotech venture creations. | Health Technology |